Paclitaxel and Conjunctivitis exacerbated - a phase IV clinical study of FDA data

Summary:

Conjunctivitis exacerbated is reported as a side effect among people who take Paclitaxel (paclitaxel), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Cyclophosphamide, and have Breast cancer metastatic.

The phase IV clinical study analyzes which people have Conjunctivitis exacerbated when taking Paclitaxel. It is created by eHealthMe based on reports of 85,850 people who have side effects when taking Paclitaxel from the FDA, and is updated regularly.

What is Paclitaxel?

Paclitaxel has active ingredients of paclitaxel. It is often used in breast cancer. eHealthMe is studying from 85,928 Paclitaxel users. Check the latest studies of Paclitaxel.

What is Conjunctivitis exacerbated?

Conjunctivitis exacerbated (bad situation of conjunctivitis) is found to be associated with 1,071 drugs and 426 conditions by eHealthMe. Check the latest studies of Conjunctivitis exacerbated.

On Jul, 31, 2026

85,850 people reported to have side effects when taking Paclitaxel.
Among them, 83 people (0.1%) have Conjunctivitis exacerbated.

Could Paclitaxel cause Conjunctivitis exacerbated?

Among these 83 people:

How long have people been on Paclitaxel when they have Conjunctivitis exacerbated? *

What is the gender of people who have Conjunctivitis exacerbated when taking Paclitaxel? *

female: 78.08 %
male: 21.92 %

What is the age of people who have Conjunctivitis exacerbated when taking Paclitaxel? *

What are other drugs people take besides Paclitaxel? *

What are other side effects people have besides Conjunctivitis exacerbated? *

Nausea (feeling of having an urge to vomit): 19 people, 22.89%
Diarrhea: 18 people, 21.69%
Blepharitis (chronic inflammation of the eyelid): 17 people, 20.48%
Cataract (clouding of the lens inside the eye): 17 people, 20.48%
Eyelid Oedema (eyelids are swollen and contain excessive fluid): 17 people, 20.48%
Dry Eyes (lack of adequate tears): 17 people, 20.48%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 14 people, 16.87%
Constipation: 14 people, 16.87%
Neuropathy Peripheral (surface nerve damage): 13 people, 15.66%
Rashes (redness): 12 people, 14.46%

What are the existing conditions these people have? *

Joint Pain: 7 people, 8.43%
Breast Cancer Metastatic: 7 people, 8.43%
High Blood Pressure: 5 people, 6.02%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 6.02%
Pain: 5 people, 6.02%
Gastric Cancer (stomach cancer): 4 people, 4.82%
Non-Small Cell Lung Cancer Stage Iv: 3 people, 3.61%
Oesophageal Carcinoma (cancer tumour of oesophagus): 2 people, 2.41%
Hypokalemia (low potassium): 2 people, 2.41%
Lung Adenocarcinoma (a form of non-small cell lung cancer): 2 people, 2.41%

* Approximation only. Some reports may have incomplete information.

Do you take Paclitaxel and have Conjunctivitis exacerbated?

- Check whether Conjunctivitis exacerbated is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Paclitaxel:

Paclitaxel (85,928 reports)

Browse all side effects of Paclitaxel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Conjunctivitis exacerbated:

Conjunctivitis exacerbated (1,071 drugs)

Browse all the conditions that are associated with Conjunctivitis exacerbated:

Conjunctivitis exacerbated (426 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on paclitaxel (the active ingredients of Paclitaxel) and Paclitaxel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.